3MELIAW M, JOHNSON P J, WILLIAM S R, et al. Induction of remission in hepatocellular carcinoma: a comparison of etopo side (VP-16) with adriamycin[J]. Cancer,1983,51:206. 被引量：1
4SHIU W C T. Primary liver cancer in Hongkong[J]. Cancer Chemother Pharmacol,1992,31(Suppl 1) :s143. 被引量：1
5PORTAC, MORONI M, NASTASI G, et al. 5-fluorouracil and leucovoricaleiumare active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase study[J].Oncology,1995,52:487. 被引量：1
6KHOO K S, AU E, KOO W H, et al. Phasell study of NSC 620212-doxorubicin HCL liposome injection (lipodox) in hepatocellular carcinoma (HCC)[abstract][J].Pro Am Soc Clin Oncol, 1996,15:226. 被引量：1
8Luo Y,Wang L,Chen C. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases[J].Journal of Gastrointestinal Surgery,2010,(12):1974-1980. 被引量：1
9Terayama N,Terada T,Nakanuma Y. Histologic growth patterns of metastatic carcinomas of the liver[J].Japanese Journal of Clinical Oncology,1996,(01):24-29. 被引量：1
10Klasen J,Heusner TA,Riegger C. Modern CT and PET/CT imaging of the liver[J].Radiologe,2011,(08):671-679. 被引量：1
